Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 7 years
- Director since
- 2023
7 years of board service in total across 2 boards, counting each seat separately. Longest: PTC Therapeutics Inc., 3 years.
PTC Therapeutics Inc.
Director
Pacira BioSciences Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 10, 2026 | Pacira BioSciences Inc. | Grant or award | +6,405 | — | — |
| Jan 5, 2026 | Bicycle Therapeutics plc | Open-market sale | −2,456 | $6.45 | $15,841 |
| Jan 5, 2026 | Bicycle Therapeutics plc | Open-market sale | −1,878 | $6.54 | $12,282 |
| Jan 2, 2026 | Bicycle Therapeutics plc | Grant or award | +50,000 | — | — |
| Jan 2, 2026 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Jan 2, 2026 | Bicycle Therapeutics plc | Open-market sale | −3,289 | $6.80 | $22,365 |
| Oct 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −217 | $8.40 | $1,823 |
| Oct 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −265 | $8.61 | $2,282 |
| Jul 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −204 | $7.09 | $1,446 |
| Jun 11, 2025 | Pacira BioSciences Inc. | Grant or award | +6,163 | — | — |
| Apr 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −215 | $8.02 | $1,724 |
| Jan 3, 2025 | PTC Therapeutics Inc. | Grant or award | +4,000 | — | — |
| Jan 2, 2025 | Bicycle Therapeutics plc | Grant or award | +35,000 | — | — |
| Jan 2, 2025 | Bicycle Therapeutics plc | Open-market sale | −1,395 | $14.09 | $19,656 |
| Jun 12, 2024 | Pacira BioSciences Inc. | Grant or award | +5,230 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.